The RANKL cytokine at 2.6 Å

September 26, 2001

The tumor necrosis factor (TNF) superfamily represents a large, loosely related, and versatile group of homotrimeric cytokines. There has been considerable interest in the structure of these proteins, and X-ray analyses are available for several of them, both in isolated form and as co-crystals with their corresponding receptors. Still, the substantial divergence in primary sequence within this family has made it difficult to predict the structure of other members with confidence. Here, Lamn et al. report a high-resolution crystal structure of the RANK ligand (RANKL), a TNF relative that acts through its receptor (RANK) to promote the differentiation and bone-resorptive activity of osteoclasts and to block apoptosis by several other cell types. As with other members of this superfamily, RANKL monomers trimerize only with each other, even when they are coexpressed with other related cytokines. Likewise, the mature trimeric protein binds specifically to RANK and not to other members of the TNF receptor family. The present crystal structure goes far toward explaining these biochemical observations. While the protein folds to form a characteristic structure that has been seen in related cytokines, there are also several solvent-exposed loops with sequences not found in other family members. Based on the well defined quaternary structure of receptors of this family, Lamm et al. predicted that one of these loops binds directly to RANK. To confirm this hypothesis, the authors mutated RANKL so that it either entirely lacks the loop in question or bears in its place a sequence from TNF. As expected, the resulting proteins form trimers normally but are incapable of interacting with RANK. This loop sequence would therefore be expected to antagonize RANK signaling and might prove useful in controlling ostoeporosis by blocking osteoclast-mediated bone resorption.

JCI Journals

Related Proteins Articles from Brightsurf:

New understanding of how proteins operate
A ground-breaking discovery by Centenary Institute scientists has provided new understanding as to the nature of proteins and how they exist and operate in the human body.

Finding a handle to bag the right proteins
A method that lights up tags attached to selected proteins can help to purify the proteins from a mixed protein pool.

Designing vaccines from artificial proteins
EPFL scientists have developed a new computational approach to create artificial proteins, which showed promising results in vivo as functional vaccines.

New method to monitor Alzheimer's proteins
IBS-CINAP research team has reported a new method to identify the aggregation state of amyloid beta (Aβ) proteins in solution.

Composing new proteins with artificial intelligence
Scientists have long studied how to improve proteins or design new ones.

Hero proteins are here to save other proteins
Researchers at the University of Tokyo have discovered a new group of proteins, remarkable for their unusual shape and abilities to protect against protein clumps associated with neurodegenerative diseases in lab experiments.

Designer proteins
David Baker, Professor of Biochemistry at the University of Washington to speak at the AAAS 2020 session, 'Synthetic Biology: Digital Design of Living Systems.' Prof.

Gone fishin' -- for proteins
Casting lines into human cells to snag proteins, a team of Montreal researchers has solved a 20-year-old mystery of cell biology.

Coupled proteins
Researchers from Heidelberg University and Sendai University in Japan used new biotechnological methods to study how human cells react to and further process external signals.

Understanding the power of honey through its proteins
Honey is a culinary staple that can be found in kitchens around the world.

Read More: Proteins News and Proteins Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to